Compound Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

Forward Citations = 422

Loading Chart...

5 inventors (with patents filed for the assignee):

Richard W Wagner (4 out of 33 patents)

Markus Kurz (3 out of 18 patents)

Robert G Kuimelis (2 out of 33 patents)

4. Dasa Lipovsek (2 out of 57 patents)

5. Peter Lohse (2 out of 10 patents)

6 patents: Sort by Forward Citations

1. 7125669 - Solid-phase immobilization of proteins and peptides (2006-10-24),

2. 7115396 - Protein scaffolds for antibody mimics and other binding proteins (2006-10-03),

3. 7078197 - Peptide acceptor ligation methods (2006-07-18),

4. 7022479 - Sensitive, multiplexed diagnostic assays for protein analysis (2006-04-04),

5. 6951725 - In vitro protein interaction detection systems (2005-10-04),

6. 6818418 - Protein scaffolds for antibody mimics and other binding proteins (2004-11-16),

Company Overview

Compound Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer. Our proprietary technology platform allows us to create highly targeted antibody-drug conjugates that deliver potent anti-cancer agents directly to tumor cells. With a strong pipeline of promising drug candidates, we are dedicated to advancing the field of oncology and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#168 in Waltham, MA

#2,548 in Massachusetts

#45,063 in US

Waltham, MA, United States of America